Claims outrun evidence
"Quantum advantage" is announced weekly. Without a named benchmark and a classical baseline, it is marketing. Buyers cannot tell which roadmap is real — and reputational risk follows the wrong bet.
Quantum Nexus grades quantum claims against classical baselines, flags missing evidence, and delivers advisor-reviewed memos your board can act on — in hours, not weeks. Evidence-first. Never hype.
Source: McKinsey Quantum Technology Monitor 2026 · NIST FIPS 203/204/205.
"Quantum advantage" is announced weekly. Without a named benchmark and a classical baseline, it is marketing. Buyers cannot tell which roadmap is real — and reputational risk follows the wrong bet.
Most funds, boards and CISOs lack in-house quantum physics and cryptography talent to diligence a deal or vendor on a deadline. Outside advisors are slow and expensive.
NIST finalized FIPS 203, 204 and 205 in August 2024. Harvest-now-decrypt-later means long-lived secrets are already exposed. Waiting is a risk decision, not a neutral one.
Frontier research does not translate into procurement paths or go/no-go memos. The evidence-grading layer between paper and boardroom decision is missing.
No quantum-advantage claim is accepted without a named benchmark, problem size, and classical comparator. Anything less is flagged needs-baseline — automatically, in every report.
The agent identifies what's absent — missing wet-lab results, undisclosed qubit error rates, unverified partner relationships — and lists what it would take to change the verdict.
Every customer-facing report passes through a human advisor before it becomes board-ready. The software enforces the gate; no approved report ships without sign-off.
Start with a high-value diligence brief. Convert it into a pilot. Convert the pilot into a recurring agent workspace.
Evaluates quantum companies, claims, papers, patents and roadmaps. Outputs a board / investor decision memo, hype-risk score, evidence table, and exportable JSON.
Maps a cryptographic inventory to NIST FIPS 203/204/205, assigns P1/P2/P3 priority by harvest-now exposure and shelf life, and delivers a phased migration plan.
Separates AI-assisted design, physics simulation, and selective quantum refinement. Produces a conservative, patent-ready evidence package with wet-lab gaps flagged.
Tracks companies, papers, grants, policy, patents, talent and public-market signals in structured, machine-readable intelligence packs delivered on a recurring schedule.
Every output separates fact, assumption, benchmark, missing evidence, and the next validation step. Each line carries a source ID and confidence.
Company, paper, patent, URL, pasted memo, or strategic question.
Pull claims, evidence, maturity and assumptions — with citations.
Compare against classical baselines; flag unsupported advantage.
Board memo + evidence table + risk scores + JSON.
Advisor review, technical benchmark, customer discovery.
Pick a claim below. The agent classifies the use case, builds an evidence table, and scores technical maturity, commercial urgency and hype-risk — then hands you a go / monitor / no-go verdict.
We benchmarked Quantum Nexus against ten leaders across quantum software, PQC security, drug discovery, advisory and autonomous agents. The whitespace is the same in every segment: agent-native, evidence-first, cross-vertical diligence.
Positioning reflects public information as of May 2026 and Quantum Nexus's own 0–6 go-to-market assessment; it is illustrative, not an endorsement or a third-party rating. Full scored matrix and sources available under NDA.
Assess quantum startups, public-company narratives and M&A targets with hype-risk scoring, patent/paper maps and a go/no-go memo.
Prepare a post-quantum cryptography transition for regulated data, vendors, protocols and board reporting.
Support quantum-AI molecular design with conservative claims, advisor review and IP-ready evidence logs.
Map quantum sensing, navigation, communications and dual-use opportunities to practical pilots and procurement paths.
Each tier removes decision risk. A single correct veto — on a bad investment, a premature vendor commitment, or an unmitigated PQC exposure — more than covers the brief. Reports become pilots; pilots become recurring agent workspaces.
One board-defensible go / monitor / no-go memo.
Deep diligence + competitive + patent map. Advisor-signed.
6–10 week pilot + saved-project agent workspace.
Advisory retainers $10k–$50k / month. Seat-based SaaS pricing after a successful pilot. Illustrative ROI: a single avoided mis-investment can exceed the cost of a brief by orders of magnitude — outcomes vary and are not guaranteed.
Every claim graded by the same five rules — no exceptions, no overrides.
We earn whether quantum arrives early, late, or sideways — because we sell the decision layer, not the hardware bet.
Quantum Nexus sells judgment — not qubits, not simulation, not chemistry. A neutral evidence-grading layer earns on any timeline: it tells investors when to commit and when to wait. No hardware conflict of interest; institutional credibility is the asset.
Fixed-price briefs ($7.5k–$75k) prove value immediately and fund the build. Each successful engagement converts to a saved-project workspace at $500–5k / seat / month. Land-and-expand from brief to pilot to recurring intelligence — without upfront SaaS risk.
The refusal to overclaim is a credibility asset. In a category prone to hype cycles, an evidence-first, advisor-reviewed posture is the inoculation. Boards and investors need defensible records; we produce them on demand. The discipline is the moat.
Equity-story detail available under NDA. Figures cited on this page are paraphrased from third-party sources; illustrative figures are labeled. Decision-support, not investment advice. Quantum Nexus Technologies Ltd is a subsidiary of Lakeside Holding Limited (Nasdaq: LSH).
NIST finalized FIPS 203 (ML-KEM), 204 (ML-DSA) and 205 (SLH-DSA) in August 2024. Harvest-now-decrypt-later is live today — adversaries are archiving TLS sessions for future decryption. Long-lived secrets are already exposed.
The PQC Migration Agent takes a cryptographic inventory and returns a phased, advisor-reviewed migration plan — mapped to the NIST standards your board needs to see.
List every system, its role (key exchange, signature, encryption, hash) and the current algorithm. Shelf life and regulatory deadline included.
RSA / ECDH → ML-KEM (FIPS 203). ECDSA / RSA-sig → ML-DSA (FIPS 204). SHA-1 / MD5 → flagged broken, P1 priority.
P1 (now) = long-shelf-life or broken. P2 (12–36 mo) = standard asymmetric track. P3 (36+ mo) = symmetric uplifts. Board-ready Markdown memo included.
A human cryptography advisor reviews and signs off before the memo ships. Every customer-facing report is in draft state until advisor approval.
Tell us the company, claim, paper or decision you are facing. We respond with scope and a fixed price within two business days.